VIJ Stock Chart & Stats
€7.70
-€0.30(-3.66%)
At close: 4:00 PM EDT
€7.70
-€0.30(-3.66%)
Day’s Range― - ―
52-Week Range€5.10 - €10.50
Previous CloseN/A
Volume0.00
Average Volume (3M)0.00
Market Cap
€331.74M
Enterprise Value€471.69M
Total Cash (Recent Filing)€10.68M
Total Debt (Recent Filing)€11.60M
Price to Earnings (P/E)25.8
Beta0.29
Next Earnings
Nov 04, 2026EPS Estimate
0.11Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.38
Shares Outstanding38,088,226
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG Ratio0.63
Price to Book (P/B)2.04
Price to Sales (P/S)1.07
P/FCF Ratio24.22
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€11.19Price Target Upside45.32% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
EPS Forecast (FY)0.37
Revenue Forecast (FY)€283.40M
Bulls Say, Bears Say
Bulls Say
Strong Revenue GrowthRapid revenue growth and a higher full-year guidance range indicate continued demand for Viemed’s home-based respiratory services. Sustained expansion improves operating leverage potential, supports investment in capacity and technology, and strengthens the company’s ability to compound over the next several quarters.
Expanding Patient BaseGrowth in active ventilator and sleep therapy patients expands Viemed’s recurring therapy-related revenue base. Improved usage compliance can support continuity of reimbursement and patient outcomes, while a larger installed base creates opportunities for follow-on equipment, resupply, monitoring, and clinical services.
Cash Generation And Low LeverageStrong operating and free cash flow, combined with net cash, gives Viemed financial flexibility to fund growth, technology investments, and working-capital needs internally. Low leverage also reduces balance-sheet risk and preserves capacity for disciplined capital allocation through changing operating conditions.
Bears Say
Margin CompressionLower adjusted EBITDA and gross margins indicate that revenue growth is not currently translating fully into operating profit. If mix and cost pressures persist, they could limit earnings conversion, reduce operating leverage, and constrain the cash available for reinvestment despite continued top-line expansion.
Lower-Margin Revenue MixA structural shift away from higher-margin ventilator rentals toward lower-margin product and service revenue may reduce profitability as the business grows. Although the newer mix is less capital-intensive, sustained mix dilution could make margin expansion harder and require stronger scale efficiencies to protect earnings.
Operating Cost And Capacity PressureFaster SG&A growth and potential respiratory therapist hiring raise the cost required to support expansion and maintain compliance. These pressures could delay operating leverage, increase the resources needed per patient, and keep profitability below its historical potential as Viemed scales.
Viemed Healthcare News
VIJ FAQ
What was Viemed Healthcare Inc’s price range in the past 12 months?
Viemed Healthcare Inc lowest stock price was €5.10 and its highest was €10.50 in the past 12 months.
What is Viemed Healthcare Inc’s market cap?
Viemed Healthcare Inc’s market cap is €331.74M.
When is Viemed Healthcare Inc’s upcoming earnings report date?
Viemed Healthcare Inc’s upcoming earnings report date is Nov 04, 2026 which is in 7 days.
How were Viemed Healthcare Inc’s earnings last quarter?
Viemed Healthcare Inc released its earnings results on Aug 03, 2026. The company reported €0.063 earnings per share for the quarter, missing the consensus estimate of €0.107 by -€0.045.
Is Viemed Healthcare Inc overvalued?
According to Wall Street analysts Viemed Healthcare Inc’s price is currently Undervalued.
Does Viemed Healthcare Inc pay dividends?
Viemed Healthcare Inc does not currently pay dividends.
What is Viemed Healthcare Inc’s EPS estimate?
Viemed Healthcare Inc’s EPS estimate is 0.11.
How many shares outstanding does Viemed Healthcare Inc have?
Viemed Healthcare Inc has 38,088,226 shares outstanding.
What happened to Viemed Healthcare Inc’s price movement after its last earnings report?
Viemed Healthcare Inc reported an EPS of €0.063 in its last earnings report, missing expectations of €0.107. Following the earnings report the stock price went down -0.508%.
Which hedge fund is a major shareholder of Viemed Healthcare Inc?
Currently, no hedge funds are holding shares in DE:VIJ
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Viemed Healthcare Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
€11.19 (45.32% Upside)
€11.19 (45.32% Upside)
Blogger Sentiment
Bullish
DE:VIJ Sentiment 60%
Sector Average 66%
Sector Average 66%
Technicals
SMA
Negative
20 days / 200 days
Momentum
40.60%
12-Months-Change
Fundamentals
Return on Equity
10.30%
Trailing 12-Months
Asset Growth
10.63%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Viemed Healthcare Inc
Viemed Healthcare, Inc., through its subsidiaries, provides home medical equipment (HME) and post-acute respiratory healthcare services in the United States. The company provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD. It also sells and rents HME devices, such as non-invasive and invasive ventilators, positive airway pressure (PAP) machines, durable medical equipment, percussion vests, oxygen concentrators, and other medical equipment. In addition, the company provides neuromuscular care and oxygen therapy services; and sleep apnea management which provides sleep solutions and/or equipment, such as PAP, automatic continuous positive airway pressure, and bi-level positive airway pressure machines. Further, it offers in-home sleep apnea testing services; and breast pumps and related lactation equipment and supplies, including fulfillment and support services, as well as healthcare staffing and recruitment services. Viemed Healthcare, Inc. was founded in 2006 and is headquartered in Lafayette, Louisiana.
VIJ Company Deck
VIJ Earnings Call
Q2 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call presented multiple material operational and financial positives: record revenue, the largest-ever active ventilator patient base, strong sequential and year-over-year growth in sleep and resupply, improving compliance, improved cash generation, and clear investments in technology and scalability (e.g., Tenor). Offsetting these were margin pressures in adjusted EBITDA and gross margin driven by revenue mix shifts, temporary maternal health transition costs, higher SG&A from deliberate scaling and one-time duplicative costs, and some near-term uncertainty on RT capacity. Management communicated confidence in the growth trajectory, provided constructive explanations for margin dynamics, and raised revenue guidance while outlining levers for second-half operating leverage.View all DE:VIJ earnings summariesVIJ Stock 12 Month Forecast
Average Price Target
€11.19
▲(45.32% Upside)
Technical Analysis
Inogen
―
Senseonics Holdings
―
Tactile Systems Technology
―
Outset Medical
―
Bioventus
―